Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzia Defina

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Blood|February 5, 2010
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopeniaFrancesco Zaja, Michele Baccarani, Patrizio Mazza, et al.
The Journal of Molecular Diagnostics : JMD|February 21, 2025
Repurposing the Whole Expression Transcriptome Assay for the Genetic Diagnosis of T-Cell Acute Lymphoblastic Leukemia and LymphomaValentina Bardelli, Silvia Arniani, Valentina Pierini, et al.
Vaccines|May 7, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 StudiesAnna Sicuranza, Massimo Breccia, Francesco Iuliano, et al.
Haematologica|January 13, 2022
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL studyMarco Cerrano, Massimiliano Bonifacio, Matteo Olivi, et al.
Cancer|October 15, 2025
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS studyAnna Sicuranza, Paola Pacelli, Adele Santoni, et al.
Haematologica|April 21, 2022
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL reportSabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, et al.
Hematological Oncology|August 11, 2025
Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All StudyPatrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2024
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment PlanMichele Malagola, Alessandra Iurlo, Cristina Bucelli, et al.
Cancers|September 28, 2023
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All StudyNicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis, et al.
Frontiers in Oncology|June 15, 2018
Residual Peripheral Blood CD26<sup>+</sup> Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free RemissionMonica Bocchia, Anna Sicuranza, Elisabetta Abruzzese, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Blood|February 5, 2010
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopeniaFrancesco Zaja, Michele Baccarani, Patrizio Mazza, et al.
The Journal of Molecular Diagnostics : JMD|February 21, 2025
Repurposing the Whole Expression Transcriptome Assay for the Genetic Diagnosis of T-Cell Acute Lymphoblastic Leukemia and LymphomaValentina Bardelli, Silvia Arniani, Valentina Pierini, et al.
Vaccines|May 7, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 StudiesAnna Sicuranza, Massimo Breccia, Francesco Iuliano, et al.
Haematologica|January 13, 2022
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL studyMarco Cerrano, Massimiliano Bonifacio, Matteo Olivi, et al.
Cancer|October 15, 2025
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS studyAnna Sicuranza, Paola Pacelli, Adele Santoni, et al.
Haematologica|April 21, 2022
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL reportSabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, et al.
Hematological Oncology|August 11, 2025
Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All StudyPatrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2024
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment PlanMichele Malagola, Alessandra Iurlo, Cristina Bucelli, et al.
Cancers|September 28, 2023
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All StudyNicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis, et al.
Frontiers in Oncology|June 15, 2018
Residual Peripheral Blood CD26<sup>+</sup> Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free RemissionMonica Bocchia, Anna Sicuranza, Elisabetta Abruzzese, et al.
Pageof 7